1
|
Carfora V, Mazzeo P, Tarsia G, Biscione C, Lopizzo A, Polosa D, Grippo R, Paternò G, Stabile E. C55 DAPT IN ELDERLY PATIENTS WITH STEMI OR VERY HIGH RISK NSTEMI: A RETROSPECTIVE STUDY COMPARING TICAGRELOR VS CLOPIDOGREL. Eur Heart J Suppl 2022. [DOI: 10.1093/eurheartj/suac011.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Abstract
Background
Elderly patients with acute coronary syndrome represent a growing population. The major problem in this population is the balancing of ischemic and bleeding risk. There are poor data from randomized clinical trials on the treatment of acute coronary syndrome in this population. We aim to analyze the best therapeutic strategy in this population.
Methods
We performed retrospective study at the Cardiology Department, San Carlo Hospital, Potenza.181 patients with an age ≥ 75 years with STEMI or very high risk NSTEMI were selected from 1 January 2018 to 31 December 2019. Exclusion criteria were anticoagulants therapy, end stage renal disease, cancer in progress and cardiogenic shock at clinical presentation. 43 patients had starter dual antiplatelet therapy with acetylsalicylic acid and clopidogrel and 76 with acetylsalicylic acid and ticagrelor. We aimed to evaluate at 12 months follow up the composite endpoints of ischemic stroke and reinfarction, stroke, bleeding events and death.
Results
At the 12–month follow–up, 15 patients died (all–cause mortality of 12.6%). There were 5 strokes (4% of population), 3 in the Clopidogrel group (6.9%) and 2 in the Ticagrelor group (2.6%) without a statistically significant difference (p 0,7463). The composite endpoint of ischemic events, stroke and reinfarction occurred in 12 patients, 6 in each group, (13.9% in the Clopidogrel group and 7.9% in the Ticagrelor group) but this difference, although indicative, is not statistically significant (p 0.2956). The only statistically significant difference occurred for BARC 2, 3 or 5 bleeding events with a significantly less events in the Clopidogrel group (4.6%) than in Ticagrelor group (18.4%) (p 0, 0345).
Conclusion
The elderly patient with STEMI or high–risk NSTEMI represent a group of patients with high ischemic risk but also high bleeding risk. The use of clopidogrel in combination with acetylsalicylic acid should be considered to reduce bleeding events without increasing ischemic events.
Collapse
Affiliation(s)
- V Carfora
- CARDIOLOGY DEPARTMENT, SAN CARLO HOSPITAL, POTENZA, POTENZA
| | - P Mazzeo
- CARDIOLOGY DEPARTMENT, SAN CARLO HOSPITAL, POTENZA, POTENZA
| | - G Tarsia
- CARDIOLOGY DEPARTMENT, SAN CARLO HOSPITAL, POTENZA, POTENZA
| | - C Biscione
- CARDIOLOGY DEPARTMENT, SAN CARLO HOSPITAL, POTENZA, POTENZA
| | - A Lopizzo
- CARDIOLOGY DEPARTMENT, SAN CARLO HOSPITAL, POTENZA, POTENZA
| | - D Polosa
- CARDIOLOGY DEPARTMENT, SAN CARLO HOSPITAL, POTENZA, POTENZA
| | - R Grippo
- CARDIOLOGY DEPARTMENT, SAN CARLO HOSPITAL, POTENZA, POTENZA
| | - G Paternò
- CARDIOLOGY DEPARTMENT, SAN CARLO HOSPITAL, POTENZA, POTENZA
| | - E Stabile
- CARDIOLOGY DEPARTMENT, SAN CARLO HOSPITAL, POTENZA, POTENZA
| |
Collapse
|
2
|
Migliaccio MG, Di Mauro M, Ricciolino R, Spiniello G, Carfora V, Verde N, Mottola FF, Coppola N. Renal Involvement in COVID-19: A Review of the Literature. Infect Drug Resist 2021; 14:895-903. [PMID: 33707958 PMCID: PMC7943324 DOI: 10.2147/idr.s288869] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2020] [Accepted: 12/17/2020] [Indexed: 01/08/2023] Open
Abstract
Kidney injury may be a severe complication of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and contributes to worsen the prognosis. Various pathophysiological mechanisms can contribute to organ damage and impair renal function, proving the complexity of the virus activity and the resulting immunity response. We summarized the evidence of the literature on the prevalence of kidney involvement, on the pathogenic pathways and on its management.
Collapse
Affiliation(s)
- Marco Giuseppe Migliaccio
- Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy
| | - Marco Di Mauro
- Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy
| | - Riccardo Ricciolino
- Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy
| | - Giorgio Spiniello
- Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy
| | - Vincenzo Carfora
- Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy
| | - Nicoletta Verde
- Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy
| | - Filiberto Fausto Mottola
- Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy
| | - Nicola Coppola
- Department of Mental Health and Public Medicine, Infectious Diseases Unit, University of Campania “Luigi Vanvitelli”, Naples, Italy
| | - On behalf of the Vanvitelli COVID-19 Group
- Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy
- Department of Mental Health and Public Medicine, Infectious Diseases Unit, University of Campania “Luigi Vanvitelli”, Naples, Italy
| |
Collapse
|
3
|
Mottola FF, Verde N, Ricciolino R, Di Mauro M, Migliaccio MG, Carfora V, Spiniello G, Coppola N. Cardiovascular System in COVID-19: Simply a Viewer or a Leading Actor? Life (Basel) 2020; 10:E165. [PMID: 32867137 PMCID: PMC7555654 DOI: 10.3390/life10090165] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2020] [Revised: 08/20/2020] [Accepted: 08/25/2020] [Indexed: 02/06/2023] Open
Abstract
As of January 2020, a new pandemic has spread from Wuhan and caused thousands of deaths worldwide. Several studies have observed a relationship between coronavirus disease (COVID-19) infection and the cardiovascular system with the appearance of myocardial damage, myocarditis, pericarditis, heart failure and various arrhythmic manifestations, as well as an increase in thromboembolic risk. Cardiovascular manifestations have been highlighted especially in older and more fragile patients and in those with multiple cardiovascular risk factors such as cancer, diabetes, obesity and hypertension. In this review, we will examine the cardiac involvement associated with SARS-CoV-2 infection, focusing on the pathophysiological mechanism underlying manifestations and their clinical implication, taking into account the main scientific papers published to date.
Collapse
Affiliation(s)
- Filiberto Fausto Mottola
- Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, 80131 Naples, Italy; (F.F.M.); (N.V.); (R.R.); (M.D.M.); (M.G.M.); (V.C.); (G.S.)
| | - Nicoletta Verde
- Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, 80131 Naples, Italy; (F.F.M.); (N.V.); (R.R.); (M.D.M.); (M.G.M.); (V.C.); (G.S.)
| | - Riccardo Ricciolino
- Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, 80131 Naples, Italy; (F.F.M.); (N.V.); (R.R.); (M.D.M.); (M.G.M.); (V.C.); (G.S.)
| | - Marco Di Mauro
- Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, 80131 Naples, Italy; (F.F.M.); (N.V.); (R.R.); (M.D.M.); (M.G.M.); (V.C.); (G.S.)
| | - Marco Giuseppe Migliaccio
- Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, 80131 Naples, Italy; (F.F.M.); (N.V.); (R.R.); (M.D.M.); (M.G.M.); (V.C.); (G.S.)
| | - Vincenzo Carfora
- Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, 80131 Naples, Italy; (F.F.M.); (N.V.); (R.R.); (M.D.M.); (M.G.M.); (V.C.); (G.S.)
| | - Giorgio Spiniello
- Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, 80131 Naples, Italy; (F.F.M.); (N.V.); (R.R.); (M.D.M.); (M.G.M.); (V.C.); (G.S.)
| | - Nicola Coppola
- Department of Mental Health and Public Medicine, Infectious Diseases Unit., University of Campania “Luigi Vanvitelli”, 80131 Naples, Italy
| | | |
Collapse
|
4
|
Roselli L, Cicia G, Del Giudice T, Cavallo C, Vecchio R, Carfora V, Caso D, Sardaro R, Carlucci D, De Gennaro B. Testing consumers’ acceptance for an extra-virgin olive oil with a naturally increased content in polyphenols: The case of ultrasounds extraction. J Funct Foods 2020. [DOI: 10.1016/j.jff.2020.103940] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
5
|
Scoccianti S, Simontacchi G, Greto D, Perna M, Terziani F, Talamonti C, Teriaca MA, Caramia G, Lo Russo M, Olmetto E, Delli Paoli C, Grassi R, Carfora V, Saieva C, Bonomo P, Detti B, Mangoni M, Desideri I, Francolini G, Di Cataldo V, Marrazzo L, Pallotta S, Livi L. Dosimetric Predictors of Acute and Chronic Alopecia in Primary Brain Cancer Patients Treated With Volumetric Modulated Arc Therapy. Front Oncol 2020; 10:467. [PMID: 32322558 PMCID: PMC7156544 DOI: 10.3389/fonc.2020.00467] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2019] [Accepted: 03/16/2020] [Indexed: 12/18/2022] Open
Abstract
Purpose: To determine dose constraints that correlate with alopecia in patients treated with photon-based Volumetric Modulated Arc Therapy (VMAT) for primary brain tumors. Methods: During the treatment planning process, the scalp was drawn as a region of interest. Dose received by 0.1 cc (D0.1cc), mean dose (Dmean), absolute volumes receiving different doses (V16Gy, V20Gy, V25Gy, V30Gy, V35Gy, V40Gy, and V43Gy) were registered for the scalp. Alopecia was assessed according to Common Terminology Criteria for Adverse Events (CTCAE) v4.0. Receiver operating characteristics (ROC) curve analysis was used to identify parameters associated with hair-loss. Results: One-hundred and one patients were included in this observational study. At the end of radiotherapy (RT), 5 patients did not develop alopecia (Dmean scalp 3.1 Gy). The scalp of the patients with G1 (n = 11) and G2 (n = 85) alopecia received Dmean of 10.6 Gy and 11.8 Gy, respectively. At ROC analysis, V16Gy20Gy ≥ 5.2 cc were the strongest predictors of acute alopecia risk. Chronic hair-loss assessment was available for 74 patients: median time to recovery from G2 alopecia was 5, 9 months. The actuarial rate of hair regrowth was 98.1% at 18 months after the end of RT. At ROC analysis, V40Gy43Gy ≥2.2 cc were the strongest predictors of chronic G2-alopecia risk. V20Gy, V40Gy, and D0,1cc were shown to be independent variables according to correlation coefficient r. Conclusions: V20Gy and V40Gy were the strongest predictors for acute and chronic G2 hair-loss, respectively. The low-dose bath typical of VMAT corresponds to large areas of acute but transient alopecia. However, the steep dose gradient of VMAT allows to reduce the areas of the scalp that receive higher doses, minimizing the risk of permanent alopecia. The application of our dosimetric findings for the scalp may help in reducing the alopecia risk and also in estimating the probability of hair-loss during patient counseling before starting radiotherapy.
Collapse
Affiliation(s)
- Silvia Scoccianti
- Radiation Oncology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
| | - Gabriele Simontacchi
- Radiation Oncology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
| | - Daniela Greto
- Radiation Oncology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
| | - Marco Perna
- Radiation Oncology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
| | - Francesca Terziani
- Radiation Oncology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
| | - Cinzia Talamonti
- Medical Physics Unit, Department of Experimental and Clinical Biomedical Sciences "Mario Serio," Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
| | - Maria Ausilia Teriaca
- Radiation Oncology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
| | - Giorgio Caramia
- Radiation Oncology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
| | - Monica Lo Russo
- Radiation Oncology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
| | - Emanuela Olmetto
- Radiation Oncology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
| | - Camilla Delli Paoli
- Radiation Oncology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
| | - Roberta Grassi
- Radiation Oncology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
| | - Vincenzo Carfora
- Radiation Oncology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
| | - Calogero Saieva
- SC Epidemiology of Risk Factors and Lifestyles, Institute for Study, Prevention, and Oncology Network (ISPRO), Florence, Italy
| | - Pierluigi Bonomo
- Radiation Oncology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
| | - Beatrice Detti
- Radiation Oncology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
| | - Monica Mangoni
- Radiation Oncology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
| | - Isacco Desideri
- Radiation Oncology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
| | - Giulio Francolini
- Radiation Oncology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
| | - Vanessa Di Cataldo
- Radiation Oncology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
| | - Livia Marrazzo
- Medical Physics Unit, Department of Experimental and Clinical Biomedical Sciences "Mario Serio," Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
| | - Stefania Pallotta
- Medical Physics Unit, Department of Experimental and Clinical Biomedical Sciences "Mario Serio," Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
| | - Lorenzo Livi
- Radiation Oncology Unit, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
| |
Collapse
|
6
|
Cesaro A, Gragnano F, Fimiani F, Moscarella E, Pariggiano I, Diana V, Carfora V, Conte M, Falato S, Cesarano M, Di Maio D, Calabrò P. Quality Of Life Improvement In High And Very High Cardiovascular Risk Patients Treated With Pcsk9 Inhibitors. Atherosclerosis 2019. [DOI: 10.1016/j.atherosclerosis.2019.06.605] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
7
|
Loi M, Di Cataldo V, Simontacchi G, Detti B, Bonomo P, Masi L, Desideri I, Greto D, Francolini G, Carfora V, Pezzulla D, Perna M, Carta G, Livi L. Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer. Clin Oncol (R Coll Radiol) 2018; 30:93-100. [DOI: 10.1016/j.clon.2017.11.007] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2017] [Revised: 10/28/2017] [Accepted: 11/06/2017] [Indexed: 12/31/2022]
|
8
|
Carfora V, Caso D, Conner M. Randomised controlled trial of a text messaging intervention for reducing processed meat consumption: The mediating roles of anticipated regret and intention. Appetite 2017; 117:152-160. [DOI: 10.1016/j.appet.2017.06.025] [Citation(s) in RCA: 42] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2017] [Revised: 06/06/2017] [Accepted: 06/22/2017] [Indexed: 01/16/2023]
|
9
|
Giacinti G, Carfora V, Caprioli A, Sagrafoli D, Marri N, Giangolini G, Amoruso R, Iurescia M, Stravino F, Dottarelli S, Feltrin F, Franco A, Amatiste S, Battisti A. Prevalence and characterization of methicillin-resistant Staphylococcus aureus carrying mecA or mecC and methicillin-susceptible Staphylococcus aureus in dairy sheep farms in central Italy. J Dairy Sci 2017; 100:7857-7863. [DOI: 10.3168/jds.2017-12940] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2017] [Accepted: 06/17/2017] [Indexed: 11/19/2022]
|
10
|
Greto D, Loi M, Scoccianti S, Baki M, Desideri I, Bordi L, Bono P, Meattini I, Bonomo P, Terziani F, Carfora V, Livi L. PO-0624: Gammaknife Radiosurgery in patients receiving anticancer immunotherapy: efficacy and safety. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31061-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
11
|
Bonomo P, Isacco D, Loi M, Carfora V, Cipressi S, Di Cataldo V, Masi L, Doro R, Bonucci I, Simontacchi G, Greto D, Scoccianti S, Livi L. Stereotactic re-irradiation for recurrent head and neck cancer: predictive factors of efficacy from a single-institution experience. Eur J Cancer 2017. [DOI: 10.1016/s0959-8049(17)30442-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
12
|
Locatelli C, Cremonesi P, Caprioli A, Carfora V, Ianzano A, Barberio A, Morandi S, Casula A, Castiglioni B, Bronzo V, Moroni P. Occurrence of methicillin-resistant Staphylococcus aureus in dairy cattle herds, related swine farms, and humans in contact with herds. J Dairy Sci 2016; 100:608-619. [PMID: 27865508 DOI: 10.3168/jds.2016-11797] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2016] [Accepted: 09/25/2016] [Indexed: 12/16/2022]
Abstract
In this study we investigated the circulation of methicillin-resistant Staphylococcus aureus (MRSA) in 2 dairy cattle farms (farm A and B), previously identified as MRSA-positive in bulk tank milk samples, and epidemiologically related to swine farms. Collected specimens included quarter milk samples and nasal swabs from dairy cows, pig nasal swabs collected at both the farm and slaughterhouse level, environmental dust samples, and human nasal swabs from the farms' owners and workers. The prevalence of MRSA was estimated at the herd level by testing quarter milk samples. The prevalence of MRSA was 4.8% (3/63; 95% confidence interval=0-10.2%) and 60% (33/55; 95% confidence interval=47.05-72.95) in farm A and B, respectively. In farm A, MRSA was also isolated from humans, pigs sampled at both farm and slaughterhouse level, and from environmental samples collected at the pig facilities. The dairy cattle facilities of farm A tested negative for MRSA. In farm B, MRSA was isolated from environmental dust samples in both the cattle and pig facilities, whereas nasal swabs collected from cows and from humans tested negative. Sixty-three selected MRSA isolates obtained from different sources in farm A and B were genetically characterized by multilocus sequence typing, spa-typing, ribosomal spacer-PCR, and also tested for the presence of specific virulence genes and for their phenotypical antimicrobial susceptibility by broth microdilution method. Different clonal complex (CC) and spa-types were identified, including CC398, CC97, and CC1, CC already reported in livestock animals in Italy. The MRSA isolates from quarter milk of farm A and B mostly belonged to CC97 and CC398, respectively. Both lineages were also identified in humans in farm A. The CC97 and CC398 quarter milk isolates were also identified as genotype GTBE and GTAF by ribosomal spacer-PCR respectively, belonging to distinct clusters with specific virulence and resistance patterns. The GTBE and GTAF clusters also included swine, environmental, and human isolates from both farms. A high heterogeneity in the genetic and phenotypic profiles was observed in environmental isolates, in particular from farm B. These results demonstrate the possibility of a dynamic sharing and exchange of MRSA lineages or genotypes between different species and farm compartments in mixed-species farms. The risk of transmission between swine and related dairy cattle herds should be considered. Our findings also confirm the zoonotic potential of livestock-associated MRSA and underline the importance of applying biosecurity measures and good hygiene practices to prevent MRSA spread at the farm level and throughout the food production chain.
Collapse
Affiliation(s)
- C Locatelli
- Dipartimento di Scienze Veterinarie per la Salute, la Produzione Animale e la Sicurezza Alimentare, Università degli Studi di Milano, 20133 Milan, Italy
| | - P Cremonesi
- Istituto di Biologia e Biotecnologia Agraria, (IBBA-CNR), via Einstein, 26900 Lodi, Italy
| | - A Caprioli
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri" General Diagnostic Department, National Reference Laboratory for Antimicrobial Resistance, Via Appia Nuova 1411, 00178 Rome, Italy
| | - V Carfora
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri" General Diagnostic Department, National Reference Laboratory for Antimicrobial Resistance, Via Appia Nuova 1411, 00178 Rome, Italy
| | - A Ianzano
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri" General Diagnostic Department, National Reference Laboratory for Antimicrobial Resistance, Via Appia Nuova 1411, 00178 Rome, Italy
| | - A Barberio
- Istituto Zooprofilattico Sperimentale delle Venezie, Vicenza viale Fiume 78, 36100 Vicenza, Italy
| | - S Morandi
- Istituto di Scienze delle Produzioni Alimentari, (ISPA-CNR), via Celoria 2, 20133 Milan, Italy
| | - A Casula
- Dipartimento di Medicina Veterinaria, Università degli Studi di Milano, 20133 Milan, Italy
| | - B Castiglioni
- Istituto di Biologia e Biotecnologia Agraria, (IBBA-CNR), via Einstein, 26900 Lodi, Italy
| | - V Bronzo
- Dipartimento di Medicina Veterinaria, Università degli Studi di Milano, 20133 Milan, Italy
| | - P Moroni
- Dipartimento di Medicina Veterinaria, Università degli Studi di Milano, 20133 Milan, Italy; Animal Heath Diagnostic Center, Quality Milk Production Services, Cornell University, Ithaca, NY 14853.
| |
Collapse
|
13
|
Carfora V, Caso D, Conner M. The role of self-identity in predicting fruit and vegetable intake. Appetite 2016; 106:23-9. [DOI: 10.1016/j.appet.2015.12.020] [Citation(s) in RCA: 52] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2015] [Revised: 10/27/2015] [Accepted: 12/18/2015] [Indexed: 11/16/2022]
|
14
|
Carfora V, Giacinti G, Sagrafoli D, Marri N, Giangolini G, Alba P, Feltrin F, Sorbara L, Amoruso R, Caprioli A, Amatiste S, Battisti A. Methicillin-resistant and methicillin-susceptible Staphylococcus aureus in dairy sheep and in-contact humans: An intra-farm study. J Dairy Sci 2016; 99:4251-4258. [PMID: 27060817 DOI: 10.3168/jds.2016-10912] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2016] [Accepted: 02/14/2016] [Indexed: 11/19/2022]
Abstract
Staphylococcus aureus is involved in a wide variety of diseases in humans and animals, and it is considered one of the most significant etiological agents of intramammary infection in dairy ruminants, causing both clinical and subclinical infections. In this study, the intra-farm prevalence and circulation of methicillin-resistant S. aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) were investigated on an Italian dairy sheep farm previously identified as MRSA-positive by testing bulk tank milk (first isolation in 2012). Human samples (nasal swabs, hand skin samples, and oropharyngeal swabs) from 3 persons working in close contact with the animals were also collected, and the genetic characteristics and relatedness of the MRSA isolates from human and animal sources within the farm were investigated. After 2yr from the first isolation, we confirmed the presence of the same multidrug-resistant strain of MRSA sequence type (ST)1, clonal complex (CC)1, spa type t127, staphylococcal cassette chromosome mec (SCCmec) type IVa, showing identical pulsed field gel electrophoresis (PFGE) and resistance profiles at the farm level in bulk tank milk. Methicillin-resistant S. aureus isolates were detected in 2 out of 556 (0.34%) individual milk samples, whereas MSSA isolates were detected in 10 samples (1.8%). The MRSA were further isolated from udder skin samples from the 2 animals that were MRSA-positive in milk and in 2 of the 3 examined farm personnel. All MRSA isolates from both ovine and human samples belonged to ST(CC)1, spa type t127, SCCmec type IVa, with some isolates from animals harboring genes considered markers of human adaptation. In contrast, all MSSA isolates belonged to ruminant-associated CC130, ST700, spa type t528. Analysis by PFGE performed on selected MRSA isolates of human and animal origin identified 2 closely related (96.3% similarity) pulsotypes, displaying only minimal differences in gene profiles (e.g., presence of the immune evasion cluster genes). Although we observed low MRSA intra-farm prevalence, our findings highlight the importance of considering the possible zoonotic potential of CC1 livestock-associated MRSA, in view of the ability to persist over years at the farm level. Biosecurity measures and good hygiene practices could be useful to prevent MRSA spread at the farm level and to minimize exposure in the community and in categories related to farm animal industry (e.g., veterinarians, farmers, and farm workers).
Collapse
Affiliation(s)
- V Carfora
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri," General Diagnostic Department, National Reference Laboratory for Antimicrobial Resistance, Via Appia Nuova 1411, 00178 Rome, Italy
| | - G Giacinti
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri," Centro di Referenza Nazionale per la Qualità del Latte e dei Prodotti Derivati degli Ovini e dei Caprini, Via Appia Nuova 1411, 00178 Rome, Italy
| | - D Sagrafoli
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri," Centro di Referenza Nazionale per la Qualità del Latte e dei Prodotti Derivati degli Ovini e dei Caprini, Via Appia Nuova 1411, 00178 Rome, Italy
| | - N Marri
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri," Centro di Referenza Nazionale per la Qualità del Latte e dei Prodotti Derivati degli Ovini e dei Caprini, Via Appia Nuova 1411, 00178 Rome, Italy
| | - G Giangolini
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri," Centro di Referenza Nazionale per la Qualità del Latte e dei Prodotti Derivati degli Ovini e dei Caprini, Via Appia Nuova 1411, 00178 Rome, Italy
| | - P Alba
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri," General Diagnostic Department, National Reference Laboratory for Antimicrobial Resistance, Via Appia Nuova 1411, 00178 Rome, Italy
| | - F Feltrin
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri," General Diagnostic Department, National Reference Laboratory for Antimicrobial Resistance, Via Appia Nuova 1411, 00178 Rome, Italy
| | - L Sorbara
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri," General Diagnostic Department, National Reference Laboratory for Antimicrobial Resistance, Via Appia Nuova 1411, 00178 Rome, Italy
| | - R Amoruso
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri," General Diagnostic Department, National Reference Laboratory for Antimicrobial Resistance, Via Appia Nuova 1411, 00178 Rome, Italy
| | - A Caprioli
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri," General Diagnostic Department, National Reference Laboratory for Antimicrobial Resistance, Via Appia Nuova 1411, 00178 Rome, Italy
| | - S Amatiste
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri," Centro di Referenza Nazionale per la Qualità del Latte e dei Prodotti Derivati degli Ovini e dei Caprini, Via Appia Nuova 1411, 00178 Rome, Italy
| | - A Battisti
- Istituto Zooprofilattico Sperimentale del Lazio e della Toscana "M. Aleandri," General Diagnostic Department, National Reference Laboratory for Antimicrobial Resistance, Via Appia Nuova 1411, 00178 Rome, Italy.
| |
Collapse
|